Skip to content

Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study

Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00623909
Enrollment
0
Registered
2008-02-26
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laser Therapy, Post Thoracotomy Pain

Keywords

Laser Therapy, Post Thoracotomy Pain, AvicennaTM laser

Brief summary

The purpose of this study is to demonstrate the safety of the AvicennaTM class IV laser for application over the skin of human subjects. In addition, we seek to measure the effectiveness and utility of this class 4 laser therapy in the treatment of post-thoracotomy pain syndrome.

Detailed description

This study was terminated prior to enrollment and closed.

Interventions

DEVICEAvicennaTM class IV laser application

AvicennaTM class IV laser for application over the skin of human subjects in the treatment of post-thoracotomy pain syndrome. Six sessions, twenty minutes applications over a period of six weeks.

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Not applicable, study terminated prior to enrollment and closed.

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Men and women age 25-65 years old with chest wall pain after lung surgery lasting more than 2 months after surgery. * Subjects shall have failed conservative treatment which may include rest, physical therapy, braces, and over the counter anti-inflammatory medications. All those enrolled will be native English speakers and have at least a high school degree

Exclusion criteria

* Subjects will be excluded if they are pregnant (which will be confirmed by a urine pregnancy test if they are of childbearing age) * Have previous history of other pain syndromes or psychiatric disorders. * We will exclude the morbidly obese (BMI \>30) because the laser may not be able to penetrate deep enough through adipose tissue. In addition, subjects who have had previous back surgery, or are on antidepressants for the treatment of depression in the preceding 6 weeks will be excluded as these may represent potential confounding factors.

Design outcomes

Primary

MeasureTime frame
The McGill pain questionnaire6 Treatments/6 Weeks

Secondary

MeasureTime frame
The visual analog scale6 Weeks
An infrared thermometer will measure skin temperature before and after the treatment6 Treatments/6 Weeks
A 4-point Likert scale (none, mild, moderate, and severe) will be used to document skin redness.6 Treatments/6 Weeks
A 4-point Likert scale (none, mild, moderate, and severe) will be used to document skin tenderness6 Treatments/6 Weeks
At the end of the study patients will rate their satisfaction with the treatment using an 11 point Likert scale where 0 means completely dissatisfied and 10 means completely satisfied.6 Treatments/6 Weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026